Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Innovation is being stifled – Lilly chief executive

February 10, 2011 Research and Development, Sales and Marketing Economist 2011 Pharma Summit, US health reforms, healthcare costs, healthcare reform, lilly

Supporting medical innovation should be a fundamental requirement of healthcare reforms, but current public policies are failing to do this, …
News
Blog footer

Digital Pharma: This is how pharma is using digital

February 10, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Android, Digital Pharma blog, Facebook, Twitter, disease awareness campaigns, ipad, iphone, social media

Pharma’s use of digital tools, from mobile apps to online campaigns to social media channels, is increasing all the time …
Feature
GSK's swine flu vaccine Pandemrix

WHO wants narcolepsy link with swine flu vaccine investigated

February 10, 2011 Research and Development, Sales and Marketing Finland Institute, GSK, GlaxoSmithKline, Pandemrix, narcolepsy, swine flu

The World Health Organisation has called for further investigation into GSK’s swine flu vaccine link to sleeping disorder narcolepsy, following …
News

Dr Mikael von Euler moves to Oncos Therapeutics

February 10, 2011 Research and Development Dr Mikael von Euler, Oncos Therapeutics, appointment, research and development

Finnish biotech company Oncos Therapeutics has appointed Dr Mikael von Euler as chief medical officer. He has more than 20 …
Appointment

Shire bags senior research execs from GSK and Abbott

February 9, 2011 Research and Development Dr Lawson Macartney, Dr Mario Saltarelli, Shire, appointment, recruitment, research and development

Shire has strengthened its speciality pharmaceuticals business with the appointment of senior research executives from GlaxoSmithKline and Abbott. Dr Lawson …
News

Dr Matthias joins Noxxon Pharma

February 9, 2011 Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development

Berlin-based biotech Noxxon Pharma has appointed Dr Matthias Baumann as chief medical officers. He joins from Focus Clinical Drug Development, …
Appointment
Advanced melanoma

Melanoma: intense competition to be the next milestone treatment

February 9, 2011 Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab

A flurry of new data has emerged in the recent months from an industry-wide pipeline of cancer drugs which could …
Feature

AZ-Targacept depression candidate moves into phase IIb

February 9, 2011 Research and Development AZ, AstraZeneca, TC-5214, Targacept, depression, major depressive disorder

AstraZeneca and Targacept have begun a phase IIb trial of TC-5214 as a ‘switch’ monotherapy for patients with depression. The …
News
AstraZeneca's Iressa (gefitinib)

AZ and Pfizer support personalised medicine database

February 8, 2011 Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine

AstraZeneca and Pfizer have teamed up with leading charity Cancer Research UK to help develop its stratified medicines programme. Stratified …
News
Pfizer research Sandwich, Kent

Pressure mounts on Pfizer and government over UK R&D closure

February 7, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee

The political fallout over Pfizer’s decision to close its Kent R&D base continues apace, with the House of Commons to …
News

Late-stage blow to AstraZeneca’s prostate cancer drug

February 7, 2011 Research and Development AstraZeneca, Cancer, prostate cancer, zibotentan

A late-stage trial of AstraZeneca’s oral prostate cancer drug zibotentan has been halted after it failed to meet its primary …
News

Bayer’s regorafenib gains orphan status for GIST

February 4, 2011 Research and Development, Sales and Marketing Bayer, FDA, GIST, gastrointestinal stromal tumours, orphan drug, regorafenib

Bayer’s investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumours (GIST) …
News
Pfizer research Sandwich, Kent

ABPI backs UK science after Pfizer’s R&D exit

February 4, 2011 Research and Development Kent, Pfizer, Sandwich

The ABPI has defended the UK’s research environment against mounting criticism following Pfizer’s decision to close its Kent research base. …
News

Working Life: Merck Sharp & Dohme medical director Paul Robinson

February 4, 2011 Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment

Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …
News

Five capabilities of centered leadership

February 3, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership

The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026